Skip to content

Measurement of observed time-to-peak effect of sufentanil in children

Measurement of observed time-to-peak effect of sufentanil in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000887
Enrollment
110
Registered
2013-10-21
Start date
2013-04-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : EEG monitoring with routine monitoring are performed in all patients who agreed to study. Before end of surgery during general anesthesia with sevoflurane at dose of 0.4MAC(MACawake), sufentan

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)110 Children aged from 2 to 12 years old and who are scheduled for elective surgery (2)patients whose American Society of Anesthesiology Physical status grade is 1 or 2

Exclusion criteria

Exclusion criteria: (1)History of CNS disease, psychiatric disorder and meningitis (2)History of drug allergy or hypersensitivity reaction

Design outcomes

Primary

MeasureTime frame
Observed time-to-peak effect from one-channel EEG

Secondary

MeasureTime frame
EKG, blood pressure and pulse oximetry

Countries

Korea, Republic of

Contacts

Public ContactJi-Hyun Lee

Seoul National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026